Amgen recruits European investors for debt sale; BMS, Brazil agree to HIV tech transfer;

 @FiercePharma: Pfizer's Lipitor hardball, from the NYT. The gist: Discounts for PBMs that block generic versions. Article | Follow @FiercePharma

> Amgen ($AMGN) is meeting with European investors this week to prepare to offer up to $1.5 billion in debt denominated in euros and British pounds. Release

> Bristol-Myers Squibb ($BMY) and the Brazilian government have signed a technology transfer agreement to expand access to the AIDS fighter Reyataz. News

> Teva Pharmaceutical Industries' ($TEVA) stock dropped after the Israeli company lost an appeal to stop Watson Pharmaceuticals ($WPI) from selling a generic version of its Seasonique birth control. Item

> GlaxoSmithKline ($GSK) won a tax-overpayment reimbursement of about $4.6 million from one Pennsylvania school district and $6.5 million from another after challenging the assessed values on several properties. More | Report

> Pfizer ($PFE) is continuing to seek buyers for its manufacturing facilities at Rouses Point and Chazy, NY. Story

Biotech News

 @FierceBiotech: BGI, Children's Hospital of Philadelphia team on next-gen sequencing, bioinformatics. Report | Follow @FierceBiotech

 @JohnCFierce: Splitsville for Athersys and Angiotech on stem cell program; Athersys inks $20M stock purchase deal. | Follow @JohnCFierce

 @RyanMFierce: Open R&D biotech model makes sense in researching PTSD. We owe it to veterans with psych scars to team up here. Article | Follow @RyanMFierce

> Analysts debate Xarelto's fate as new data points to $1B ACS market. Story

> Alimera, pSivida shares take a beating on FDA's Iluvien rejection. Report

> WuXi creates $50M VC fund for "great minds" in life sciences. News

Medical Device News

> Report: S&N to raise R&D budget. Item

> OrbusNeich releases data on combo stent, Genous. Report

> Stryker to cut 5% of workforce. Article

Biotech IT News

> Dell puts cloud-computing muscle behind personalized cancer trial. Report

> BGI, Children's Hospital of Philadelphia team on next-gen sequencing, bioinformatics. Article

> Foldit strategies uncovered, spotlights open R&D breakthrough. News

> Y Combinator alum Comprehend lands $1.2M seed round for clinical data analytics. Story

And Finally... Adolescent girls with a family history of breast disease should avoid alcohol, a new study finds. Release

Suggested Articles

An oncologist leader RBC Capital Markets interviewed expressed comfort that Trodelvy will succeed in earlier-line TNBC and in HR-positive disease.

Gilead Sciences is the latest drugmaker to settle Justice Department claims that its charity contributions were actually kickbacks.

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.